Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii;Bombas de expulsión multidrogas en Acinetobacter baumannii y resistencia a antimicrobianos

Revista Chilena de Infectologia

Volumn 26, Issue 6, 2009, Pages 499-503

  Opazo C, Andrés ^a   Mella M, Sergio ^a   Domínguez Y, Mariana ^a   Bello T, Helia ^a   González R, Gerardo ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Acinetobacter baumannii; Chile; Efflux pumps; Multi resistance; Nosocomial acquired infections

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN;

ACINETOBACTER BAUMANNII; DRUG EFFECT; METABOLISM; MULTIDRUG RESISTANCE; PHYSIOLOGY; REVIEW;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MEMBRANE TRANSPORT PROTEINS;

EID: 77950212451     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Bergogne-Berezin E, Towner K J. Acinetobacterspp. as nosocomial pathogens: microbiological,clinical, and epidemiological features. Clin Microbiol Rev 1996; 9 (2): 148-65.
2. Peleg A, Seifert H, Paterson D. Acinetobacterbaumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21 (3): 538-82.
3. Poirel L, Nordmann P. Carbapenem resistancein Acinetobacter baumannii: mechanism andepidemiology. Clin Microbiol Infect 2006; 12: 826-36.
4. Diomedi A. Infecciones por Acinetobacterbaumannii pan-resistente. Consideracionesepidemiológicas y de manejo antimicrobianoactualizado. Rev Chil Infect 2005; 22 (4): 298-320.
5. Dijkshoorn L, Nemec A, Seifert H. Anincreasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-51.
6. Martínez M A, Pinto M E, Giglio M S, Pommier J, Muñoz L M. Identificación y sensibilidad de Acinetobacter sp aislados en muestras clínicasy ambiente hospitalario. Rev Méd Chile 1992; 120: 1267-72.
7. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacterbaumannii on dry surfaces: comparison ofoutbreak and sporadic isolates. J Clin Microbiol 1998; 36 (7): 1938-41.
8. Vila J, Martí S, Sánchez-Céspedes J. Porins,efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 1210-5.
9. Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P. AdeIJK, a resistance-nodulation-cell division pump effluxing multipleantibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother 2008; 52 (2): 557-62.
10. González G, Mella S, Zemelman R, Bello H, Domínguez M. Integrones y cassettes genéticosde resistencia: estructura y rol frente a los anti-bacterianos. Rev Méd Chile 2004; 132: 619-26.
11. Fernández-Cuenca F, Martínez-Martínez L, Conejo M C, Ayala J, Perea E, Pascual A. Relationship between β-lactamase production,outer membrane protein and penicillin-bindingprotein profiles om the activity of carbape-nems against clinical isolates of Acinetobacterbaumannii. J Antimicrob Chemother 2003; 51: 565-74.
12. Limansky A, Mussi M A, Viale A. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated withimipenem resistance. J Clin Microbiol 2002; 40 (12): 4776-8.
13. Mussi M, Relling V, Limansky A, Viale A. CarO, an Acinetobacter baumannii outermembrane protein involved in carbapenemresistance, is essential for L-ornitine uptake. FEBS Lett 2007; 581: 5573-8.
14. Héritier C, Poirel L, Fournier PE, Claverie J M, Raoult D, Nordmann P. Characterizationof the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49 (10): 4174-9.
15. Nikaido H. Prevention of drug access tobacterial targets: permeability barriers andactive efflux. Science 1994; 264: 382-8.
16. Sánchez P. Sistemas MDR y resistencia a losantimicrobianos. Rev Esp Quimioterap 2003; 16 (2): 172-87.
17. Zhi X, Nikaido H. Efflux-mediated drugresistance in bacteria. Drugs 2004; 62 (2): 159-204.
18. Fath M, Kolter R. ABC transporters: Bacterialexporters. Microbiol Rev 1993; 57 (4): 995-1017.
19. Pao S, Paulsen I, Saier M. Major facilitatorsuperfamily. Microbiol Mol Biol Rev 1998; 62 (1): 1-34.
20. Saier H, Tam R, Reizer A, Reizer J. Twonovel families of bacterial membrane proteinsconcerned with nodulation, cell division andtransport. Mol Microbiol 1994; 11 (5): 841-7.
21. Brown M, Paulsen I, Skurray R. The multidrugefflux protein NorM is a prototype of a newfamily of transporters. Mol Microbiol 1999; 31: 393-5.
22. Su X, Chen J, Mizushima T, Kuroda T, Tsuchiya T. AdeM, an H+-coupled Acinetobacterbaumannii multidrug efflux pump belongingto the MATE family transporters. Antimicrob Agents Chemother 2005; 49 (10): 4362-4.
23. Paulsen I, Brown M, Skurray R. Proton-dependent multidrug efflux systems. Microbiol Rev 1996; 60 (4): 575-608.
24. Law C, Maloney P, Wang D. Ins and outs ofmajor facilitator superfamily antiporters. Annu Rev Microbiol 2008; 62: 289-305.
25. Martí S, Fernández-Cuenca F, Pascual A, Ribera A, Rodríguez-Baño J, Bou G, et al. Prevalencia de los genes tetA y tetB comomecanismo de resistencia a tetraciclina yminociclina en aislamientos clínicos de Acinetobacter baumannii. Enferm Infecc Microbiol Clin 2006; 24 (2): 77-80
26. Ribera A, Roca I, Ruiz J, Gibert I, Vila J. Partialcharacterization of a transposon containingthe tet(A) determinant in a clinical isolate of Acinetobacter baumannii. J Antimicrob Chemother 2003; 52: 477-80
27. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, et al. Comparative genomicsof multidrug resistance in Acinetobacter baumannii. PloS Genet 2 2006; 2 (1): 62-72
28. Poole K. Efflux-mediated antimicrobialresistance. J Antimicrob Chemother 2005; 56: 20-51.
29. Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E. Multidrugresistant Acinetobacter baumannii-the roleof AdeABC (RND family) efflux pump inresistance to antibiotics. Folia Histochem Cytobiol 2008; 46 (3): 257-67.
30. Magnet S, Courvalin P, Lambert T. Resistance-nodulation-cell division-type efflux pump in-volved in aminoglycoside resistance in Acineto-bacter baumannii strain BM4454. Antimicrob Agents Chemother 2001; 45 (12): 3375-80.
31. Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-type effluxpump AdeABC in Acinetobacter baumannii isregulated by the AdeRS two-component system. Antimicrob Agents Chemother 2004; 48 (9): 3298-304.
32. Piddok L. Clinically relevant chromosomallyencoded multidrug resistance efflux pumps inbacteria. Clin Microbiol Rev 2006; 19 (2): 382-402.
33. Van Bambeke F, Balzi E, Tulkens P. Antibioticefflux pumps. Biochem Pharmacol 2000; 60: 457-70.
34. Ruzin A, Keeney D, Bradford P. AdeABCmultidrug efflux pump is associated withdecreased susceptibility to tigecycline in Aci-netobacter calcoaceticus-Acinetobacterbaumannii complex. J Antimicrob Chemother 2007; 59: 1001-4.
35. Huang L, Sun L, Xu G, Xia T. Differentialsusceptibility to carbapenems due to the AdeABC efflux pump among nosocomialoutbreak isolates of Acinetobacter baumannii ina Chinese hospital. Diagn Microbiol Infect Dis 2008; 62: 326-32.
36. Lin L, Ling BD, Li XL. Distribution of themultidrug efflux pump genes, adeABC, adeDEand adeIJK, and class 1 integron genes inmultiple-antimicrobial-resistant clinical isolatesof Acinetobacter baumannii-Acinetobactercalcoaceticus complex. Int J Antimicrob Agents 2009; 33 (1): 27-32.
37. Pannek S, Higgins P, Steinke P, Jonas D, Akova M, Bohnert J, et al. Multidrug effluxinhibition in Acinetobacter baumannii:comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide. J Antimicrob Chemother 2006; 57: 970-4.
38. Sinha M, Srinivasa H. Mechanism of resist-ance to carbapenems in meropenem-resistant Acinetobacter baumannii isolates from clinicalsamples. Indian J Med Microbiol 2007; 25 (2): 212-5.